Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine.
about
Thiopurine monitoring in children with inflammatory bowel disease: a systematic reviewIdiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment OptionsReview article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.Successful Treatment of Small Intestinal Bleeding in a Crohn's Patient with Noncirrhotic Portal Hypertension by Transjugular Portosystemic Shunt Placement and Infliximab Treatment.Use of thiopurines in inflammatory bowel disease: Safety issues.Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and OutcomesAdverse events in IBD: to stop or continue immune suppressant and biologic treatmentReview article: acute severe ulcerative colitis - evidence-based consensus statements.Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement.Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review.Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.The significance of nonobstructive sinusoidal dilatation of the liver: Impaired portal perfusion or inflammatory reaction syndrome.Toxicity and response to thiopurines in patients with inflammatory bowel disease.Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era.The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease.Editorial: can we get more clinical benefit from thiopurine metabolite testing?Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy.
P2860
Q26859122-5E1D589F-40F0-4C6E-9BC1-68C5C494B2DDQ28084761-381DD9CE-70DC-44C9-8DDC-E31AC6AD89A0Q33410771-F6A8E7DE-9939-4A09-B720-FE77566C13E8Q33437400-BB680F4B-7728-48E8-AE43-B4D5A92AB606Q33621267-E1B6132A-F973-40CD-B7BA-6B8307A65BA5Q33654733-368134E8-BA9F-4E19-B6AD-1F9CAB917C73Q33894632-92105A6B-F49A-433E-8F24-8A77C762FAE5Q34073191-AC37A3F4-A2AA-44D5-9800-5E03F6AAB02BQ34528270-8DAC7B63-6390-4026-8BBA-810491522715Q35656931-AE1C5851-23A9-4F18-8372-7C45720EC347Q37373306-550FF3D7-0CF7-4EB2-9E64-CE21C9448D1BQ38179509-34F27BA7-21C7-43C0-AE55-4C35E04449A9Q38356626-A4427AB0-BBD2-4459-9599-E9AC90C4B32DQ38443981-98AADB12-C3EA-467E-B03F-F080680A654CQ39119181-FD15E9B8-D283-4A8B-B1B4-3D8BC32717A0Q39534066-CD6FD54E-B638-4BF4-8819-67F130F0935BQ48223472-07C85577-CFEA-43C4-B55F-A48B793C89A6Q50217361-1C228FF6-A6D1-454D-A210-808BD200BB54
P2860
Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Incidence of nodular regenerat ...... nts treated with azathioprine.
@en
Incidence of nodular regenerat ...... nts treated with azathioprine.
@nl
type
label
Incidence of nodular regenerat ...... nts treated with azathioprine.
@en
Incidence of nodular regenerat ...... nts treated with azathioprine.
@nl
prefLabel
Incidence of nodular regenerat ...... nts treated with azathioprine.
@en
Incidence of nodular regenerat ...... nts treated with azathioprine.
@nl
P2093
P356
P1476
Incidence of nodular regenerat ...... nts treated with azathioprine.
@en
P2093
Gwenolla Vernier-Massouille
Jacques Cosnes
Jean-Yves Mary
Marc Lémann
Philippe Seksik
P304
P356
10.1002/IBD.21330
P577
2011-02-01T00:00:00Z